Sacral neuromodulation for refractory overactive bladder after prior intravesical onabotulinumtoxinA treatment.

about

Sacral neuromodulation for refractory overactive bladder after prior intravesical onabotulinumtoxinA treatment.

Item

http://www.wikidata.org/entity/Q38950244

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Sacral neuromodulation for ref ...... onabotulinumtoxinA treatment.

@en

type

Item

label

Sacral neuromodulation for ref ...... onabotulinumtoxinA treatment.

@en

prefLabel

Sacral neuromodulation for ref ...... onabotulinumtoxinA treatment.

@en

P1476

Sacral neuromodulation for ref ...... onabotulinumtoxinA treatment.

@en

P2093

Ailsa Wilson Edwards

http://www.w3.org/2001/XMLSchema#string

Johan Gani

http://www.w3.org/2001/XMLSchema#string

Nathan Hoag

http://www.w3.org/2001/XMLSchema#string

Samantha Pillay

http://www.w3.org/2001/XMLSchema#string

Sophie Plagakis

http://www.w3.org/2001/XMLSchema#string

P2860

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment

Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA).

Validation of a patient reported outcome questionnaire for assessing success of endoscopic prostatectomy.

Sacral neuromodulation and refractory overactive bladder: an emerging tool for an old problem.

Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada

Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review.

Efficacy and adverse events of sacral nerve stimulation for overactive bladder: A systematic review.

Sacral neuromodulation for refractory overactive bladder, interstitial cystitis, and painful bladder syndrome.

Persistence with mirabegron therapy for overactive bladder: A real life experience.

P304

1377-1381

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/NAU.23117

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27612039

http://www.w3.org/2001/XMLSchema#string